Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Circleville › NPI 1326020447
Hospital

Ohiohealth Berger Hospital LLC

Ohiohealth Berger Hospital LLC was paid $16.38M by Medicaid between Jan 2018 and Dec 2024, across 262 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoOHIOHEALTH BERGER HOSPITAL LLC
CIRCLEVILLE, OH 43113
33aNPI1326020447assigned 11/15/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$16.38M
24GClaims443,399
24DCodes billed262
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#58 of 101
Median peer was paid$22.32M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BROWNING, MICHAEL controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201831,469$1.08M
201917,067$559K
202027,145$1.13M
202148,058$1.96M
202262,306$2.61M
2023145,748$5.16M
2024incomplete111,606$3.88M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 25,364 23,602 $2.94M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 19,086 17,290 $2.39M
96361 Intravenous infusion, hydration; each additional hour 13% 6,918 5,183 $2.19M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.1% 7,333 6,516 $993K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.4% 7,014 6,540 $718K
74177 Computed tomography, abdomen and pelvis; with contrast material 4.2% 2,779 2,419 $683K
59025 Fetal non-stress test 3.8% 3,664 1,452 $616K
70450 Computed tomography, head or brain; without contrast material 3.4% 2,315 2,018 $550K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.6% 1,611 1,398 $433K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 2,288 1,794 $264K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.6% 4,083 1,212 $264K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.5% 1,339 1,108 $248K
250 more codes
71275 Computed tomographic angiography, chest, with contrast material 1.3% 831 $216K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.1% 953 $178K
G0378 Hospital observation service, per hour 1.0% 2,582 $164K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,140 $154K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,382 $146K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,492 $139K
99213 Doctor's office visit, returning patient (routine) <1% 1,773 $134K
80048 Basic metabolic panel (calcium, ionized) <1% 15,421 $127K
80053 Comprehensive metabolic panel <1% 12,945 $124K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 578 $120K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,562 $116K
97602 <1% 820 $113K
99214 Doctor's office visit, returning patient (more involved) <1% 964 $93K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,546 $93K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 504 $78K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 32,391 $78K
84443 Thyroid stimulating hormone (TSH) <1% 5,081 $76K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 362 $73K
0240U <1% 459 $73K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 3,464 $64K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 683 $64K
80061 Lipid panel <1% 4,406 $61K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,469 $55K
36415 Collection of venous blood by venipuncture <1% 36,452 $54K
93976 <1% 369 $52K
83036 Hemoglobin; glycosylated (A1C) <1% 3,378 $49K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,769 $48K
82607 <1% 1,853 $41K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 434 $40K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,334 $38K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 465 $38K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,426 $38K
71250 <1% 471 $34K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 187 $34K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 201 $31K
86703 <1% 1,082 $28K
77063 Screening digital breast tomosynthesis, bilateral <1% 614 $27K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 228 $27K
86803 <1% 1,356 $26K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 76 $25K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 145 $25K
J3490 Unclassified drugs <1% 2,280 $23K
85027 <1% 3,141 $22K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 158 $21K
93971 <1% 279 $21K
73221 <1% 100 $21K
71046 Radiologic examination, chest; 2 views <1% 2,093 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,055 $20K
70496 <1% 83 $20K
97162 <1% 419 $20K
82728 <1% 1,040 $18K
84702 <1% 1,261 $17K
76830 Ultrasound, transvaginal <1% 367 $17K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 34 $17K
74018 <1% 577 $17K
96367 <1% 376 $16K
71045 Radiologic examination, chest; single view <1% 6,900 $15K
84439 <1% 1,023 $15K
82746 <1% 1,049 $15K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,852 $15K
82805 <1% 733 $15K
80348 <1% 695 $14K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 524 $14K
93017 <1% 203 $14K
86900 <1% 1,016 $13K
87340 <1% 723 $13K
86850 <1% 967 $13K
72100 <1% 519 $13K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 723 $12K
86780 <1% 601 $12K
82248 <1% 5,483 $11K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,402 $11K
64483 <1% 19 $11K
82570 <1% 1,326 $10K
72141 <1% 60 $10K
73630 <1% 703 $10K
83735 <1% 3,964 $10K
72125 Computed tomography, cervical spine; without contrast material <1% 517 $9K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,434 $9K
83540 <1% 966 $9K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 956 $9K
87653 <1% 274 $9K
76536 <1% 69 $8K
87081 <1% 687 $8K
86592 <1% 423 $8K
77067 Screening mammography, bilateral, including computer-aided detection <1% 630 $8K
82043 <1% 1,093 $8K
83550 <1% 932 $7K
80076 <1% 1,802 $7K
84484 <1% 6,676 $7K
86762 <1% 433 $7K
86140 <1% 460 $7K
87077 <1% 1,067 $7K
85610 <1% 3,672 $7K
76642 <1% 71 $7K
81001 <1% 15,215 $6K
87070 <1% 510 $6K
71271 <1% 42 $6K
70551 Magnetic resonance imaging, brain; without contrast material <1% 30 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,543 $6K
84153 <1% 348 $6K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 115 $6K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 16 $5K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 850 $5K
84403 <1% 250 $5K
72131 <1% 71 $5K
95886 <1% 12 $4K
80051 <1% 3,213 $4K
83880 <1% 1,848 $4K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 27 $4K
73610 <1% 466 $4K
97163 <1% 101 $4K
73030 <1% 407 $4K
86787 <1% 205 $4K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 151 $4K
73560 <1% 625 $3K
84460 <1% 723 $3K
86901 <1% 725 $3K
73130 <1% 497 $3K
87186 <1% 900 $3K
70498 <1% 86 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 56 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 5,764 $3K
84450 <1% 653 $3K
94060 <1% 27 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,353 $3K
85652 <1% 698 $3K
82950 <1% 243 $3K
83605 <1% 4,200 $2K
87205 <1% 466 $2K
70486 <1% 28 $2K
94726 <1% 44 $2K
90715 <1% 116 $2K
84703 <1% 3,851 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 7,609 $2K
97166 <1% 42 $2K
82565 <1% 3,435 $2K
93970 <1% 15 $2K
94729 <1% 45 $2K
82077 <1% 1,063 $2K
73502 <1% 154 $2K
73700 <1% 14 $2K
82553 <1% 186 $1K
84520 <1% 3,297 $1K
83690 <1% 5,221 $1K
72110 <1% 38 $1K
87634 <1% 480 $1K
85730 <1% 1,004 $1K
82947 <1% 3,255 $1K
96376 <1% 1,097 $1K
99215 Doctor's office visit, returning patient (complex) <1% 13 $1K
93922 <1% 15 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,529 $1K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 69 $1K
82105 <1% 41 $1K
82677 <1% 27 $973.67
84270 <1% 60 $945.70
84156 <1% 361 $915.46
86038 <1% 39 $903.29
87040 <1% 1,261 $822.06
97161 <1% 39 $812.55
99203 Doctor's office visit, new patient (routine) <1% 24 $811.37
73110 <1% 242 $789.81
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 150 $744.92
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,709 $727.92
84550 <1% 352 $710.03
87480 <1% 30 $623.87
85379 <1% 1,455 $603.51
83695 <1% 49 $543.66
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 515 $539.71
83615 <1% 337 $523.14
84100 <1% 211 $451.56
J1170 Injection, hydromorphone, up to 4 mg <1% 1,588 $446.74
88142 <1% 13 $437.00
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,026 $433.63
80069 <1% 22 $431.52
82550 <1% 342 $392.75
83001 <1% 27 $372.69
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,690 $350.81
87510 <1% 30 $345.03
J1815 Injection, insulin, per 5 units <1% 180 $327.09
72040 <1% 15 $323.78
82627 <1% 12 $285.27
97116 <1% 23 $272.33
J1650 Injection, enoxaparin sodium, 10 mg <1% 678 $248.08
81025 <1% 752 $246.73
J2270 Injection, morphine sulfate, up to 10 mg <1% 514 $242.28
85018 <1% 822 $236.78
86376 <1% 12 $232.28
J3535 Drug administered through a metered dose inhaler <1% 41 $218.82
J2704 Injection, propofol, 10 mg <1% 2,449 $216.65
J1030 Injection, methylprednisolone acetate, 40 mg <1% 77 $203.60
86336 <1% 41 $184.80
83525 <1% 12 $170.05
72050 <1% 12 $163.16
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,824 $162.13
83970 <1% 12 $139.36
86706 <1% 13 $130.30
80143 <1% 130 $107.27
70360 <1% 15 $100.90
73080 <1% 55 $100.90
80179 <1% 141 $96.44
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,326 $95.00
82375 <1% 354 $83.74
82040 <1% 14 $78.54
71101 <1% 32 $76.12
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 443 $74.14
J7050 Infusion, normal saline solution, 250 cc <1% 1,052 $73.30
J0690 Injection, cefazolin sodium, 500 mg <1% 1,194 $66.22
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 13 $65.80
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 145 $64.82
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 359 $58.38
82140 <1% 34 $49.78
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 709 $46.59
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 741 $44.19
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,186 $42.81
83050 <1% 344 $39.56
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 888 $38.46
87147 <1% 13 $36.87
81003 <1% 223 $34.53
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 646 $23.81
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 184 $23.70
C9113 Injection, pantoprazole sodium, per vial <1% 27 $19.28
36416 <1% 531 $18.10
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,487 $17.45
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 506 $16.39
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 317 $8.71
J1644 Injection, heparin sodium, per 1000 units <1% 33 $7.88
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 20 $7.56
J0780 Injection, prochlorperazine, up to 10 mg <1% 293 $6.56
J3360 Injection, diazepam, up to 5 mg <1% 51 $5.96
J1940 Injection, furosemide, up to 20 mg <1% 28 $3.53
J7510 Prednisolone oral, per 5 mg <1% 12 $2.38
J1596 Injection, glycopyrrolate, 0.1 mg <1% 14 $2.10
J2060 Injection, lorazepam, 2 mg <1% 20 $1.18
J1171 Injection, hydromorphone, 0.1 mg <1% 31 $0.46
82010 0% 124 $0.00
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 0% 40 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 132 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 122 $0.00
51701 0% 13 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 379 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 62 $0.00
88304 0% 107 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 31 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 42 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 41 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 93 $0.00
C1769 Guide wire 0% 28 $0.00
73090 0% 37 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBROWNING, MICHAEL (CFO, OHIOHEALTH)
Parent organizationOHIOHEALTH CORPORATION
Same official

Other billing entities under BROWNING, MICHAEL

Full network →
ProviderLocationPaid
Ohiohealth CorporationColumbus, OH$214.99M
Ohiohealth CorporationColumbus, OH$76.95M
Ohiohealth CorporationColumbus, OH$72.29M
Ohiohealth CorporationColumbus, OH$44.08M
Medcentral Health SystemMansfield, OH$36.92M
Marion General Hospital, INC.Marion, OH$36.47M
Sheltering Arms Hospital Foundation, INC.Athens, OH$26.88M
Ohiohealth CorporationDublin, OH$11.81M
Grady Memorial HospitalDelaware, OH$9.51M
Hardin Memorial HospitalKenton, OH$7.27M
Medcentral Health SystemMansfield, OH$3.13M
Madison Family Health CorporationLondon, OH$1.03M
Marion General Hospital, INC.Marion, OH$683K
Medcentral Health SystemMansfield, OH$477K
Sheltering Arms Hospital FoundationAthens, OH$435K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.